Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Subramanian Krishnakumar

Showing results (151-160 of 180) with videos related to

Pageof 18
Sort By:
Investigative Ophthalmology & Visual Science|May 7, 2011
Reversal of stathmin-mediated microtubule destabilization sensitizes retinoblastoma cells to a low dose of antimicrotubule agents: a novel synergistic therapeutic interventionMoutushy Mitra, Mallikarjuna Kandalam, Curam S Sundaram, et al.
Cancer|February 26, 2004
Major histocompatibility antigens and antigen-processing molecules in retinoblastomaSubramanian Krishnakumar, Amirthalakshmi Sundaram, Dhiraj Abhyankar, et al.
Plos One|January 7, 2014
Targeted expression of suicide gene by tissue-specific promoter and microRNA regulation for cancer gene therapyRavikanth Danda, Gopinath Krishnan, Kalaivani Ganapathy, et al.
Investigative Ophthalmology & Visual Science|June 21, 2008
Lysyl oxidase activity in the ocular tissues and the role of LOX in proliferative diabetic retinopathy and rhegmatogenous retinal detachmentKarunakaran Coral, Narayanasamy Angayarkanni, Jagadeesan Madhavan, et al.
Anticancer Research|July 3, 2017
Neocarzinostatin, Aptamer Conjugates for Targeting EpCAM-positive Tumor CellsPrasanna Kumar Athyala, Jagat Rakesh Kanwar, Srujana Chitipothu, et al.
Journal of Pediatric Hematology/Oncology|March 6, 2009
Expression of high mobility group A2 protein in retinoblastoma and its association with clinicopathologic featuresNalini Venkatesan, Mallikarjuna Kandalam, Gunisha Pasricha, et al.
International Ophthalmology|March 17, 2021
Intravitreal rituximab monotherapy for management of eyes with vitreoretinal lymphoma: initial experience from IndiaPukhraj Rishi, Pradeep T Manchegowda, Harshal P Gondhale, et al.
Nanomedicine (London, England)|July 15, 2014
Fe-bLf nanoformulation targets survivin to kill colon cancer stem cells and maintains absorption of iron, calcium and zincJagat R Kanwar, Ganesh Mahidhara, Kislay Roy, et al.
International Journal of Nanomedicine|November 16, 2013
Synthesis and characterization of surface-enhanced Raman-scattered gold nanoparticlesSushma Kalmodia, Jaidev Harjwani, Raguraman Rajeswari, et al.
Journal of Biomedical Science|November 9, 2020
Correction to: EpCAM aptamer mediated cancer cell specific delivery of EpCAM siRNA using polymeric nanocomplexNithya Subramanian, Jagat R Kanwar, Prasanna Kumar Athalya, et al.
Pageof 18

Showing results (151-160 of 180) with videos related to

Sort By:
Pageof 18
Investigative Ophthalmology & Visual Science|May 7, 2011
Reversal of stathmin-mediated microtubule destabilization sensitizes retinoblastoma cells to a low dose of antimicrotubule agents: a novel synergistic therapeutic interventionMoutushy Mitra, Mallikarjuna Kandalam, Curam S Sundaram, et al.
Cancer|February 26, 2004
Major histocompatibility antigens and antigen-processing molecules in retinoblastomaSubramanian Krishnakumar, Amirthalakshmi Sundaram, Dhiraj Abhyankar, et al.
Plos One|January 7, 2014
Targeted expression of suicide gene by tissue-specific promoter and microRNA regulation for cancer gene therapyRavikanth Danda, Gopinath Krishnan, Kalaivani Ganapathy, et al.
Investigative Ophthalmology & Visual Science|June 21, 2008
Lysyl oxidase activity in the ocular tissues and the role of LOX in proliferative diabetic retinopathy and rhegmatogenous retinal detachmentKarunakaran Coral, Narayanasamy Angayarkanni, Jagadeesan Madhavan, et al.
Anticancer Research|July 3, 2017
Neocarzinostatin, Aptamer Conjugates for Targeting EpCAM-positive Tumor CellsPrasanna Kumar Athyala, Jagat Rakesh Kanwar, Srujana Chitipothu, et al.
Journal of Pediatric Hematology/Oncology|March 6, 2009
Expression of high mobility group A2 protein in retinoblastoma and its association with clinicopathologic featuresNalini Venkatesan, Mallikarjuna Kandalam, Gunisha Pasricha, et al.
International Ophthalmology|March 17, 2021
Intravitreal rituximab monotherapy for management of eyes with vitreoretinal lymphoma: initial experience from IndiaPukhraj Rishi, Pradeep T Manchegowda, Harshal P Gondhale, et al.
Nanomedicine (London, England)|July 15, 2014
Fe-bLf nanoformulation targets survivin to kill colon cancer stem cells and maintains absorption of iron, calcium and zincJagat R Kanwar, Ganesh Mahidhara, Kislay Roy, et al.
International Journal of Nanomedicine|November 16, 2013
Synthesis and characterization of surface-enhanced Raman-scattered gold nanoparticlesSushma Kalmodia, Jaidev Harjwani, Raguraman Rajeswari, et al.
Journal of Biomedical Science|November 9, 2020
Correction to: EpCAM aptamer mediated cancer cell specific delivery of EpCAM siRNA using polymeric nanocomplexNithya Subramanian, Jagat R Kanwar, Prasanna Kumar Athalya, et al.
Pageof 18